Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma

Bibliographic Details
Main Authors: Cesar A. Virgen, MD, PhD, Tuyet A. Nguyen, MD, Cosimo Di Raimondo, MD, Arya Amini, MD, Kim A. Margolin, MD, Vishwas Parekh, MD, Farah R. Abdulla, MD, Badri Modi, MD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512620300242
_version_ 1811193807672180736
author Cesar A. Virgen, MD, PhD
Tuyet A. Nguyen, MD
Cosimo Di Raimondo, MD
Arya Amini, MD
Kim A. Margolin, MD
Vishwas Parekh, MD
Farah R. Abdulla, MD
Badri Modi, MD
author_facet Cesar A. Virgen, MD, PhD
Tuyet A. Nguyen, MD
Cosimo Di Raimondo, MD
Arya Amini, MD
Kim A. Margolin, MD
Vishwas Parekh, MD
Farah R. Abdulla, MD
Badri Modi, MD
author_sort Cesar A. Virgen, MD, PhD
collection DOAJ
first_indexed 2024-04-12T00:15:35Z
format Article
id doaj.art-20b36334875b480e96079599a202a613
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-12T00:15:35Z
publishDate 2020-03-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-20b36334875b480e96079599a202a6132022-12-22T03:55:50ZengElsevierJAAD Case Reports2352-51262020-03-0163195197Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinomaCesar A. Virgen, MD, PhD0Tuyet A. Nguyen, MD1Cosimo Di Raimondo, MD2Arya Amini, MD3Kim A. Margolin, MD4Vishwas Parekh, MD5Farah R. Abdulla, MD6Badri Modi, MD7Department of Dermatology, University of California–Irvine, Irvine, Los AngelesDepartment of Dermatology, Kaiser Permanente–Los Angeles Medical Center, Duarte, CaliforniaDivision of Dermatology, City of Hope National Medical Center, Duarte, California; Policlinico Tor Vergata, Rome, ItalyDepartment of Radiation Oncology, City of Hope National Medical Center, Duarte, CaliforniaDepartment of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CaliforniaDepartment of Pathology, City of Hope National Medical Center, Duarte, CaliforniaDivision of Dermatology, City of Hope National Medical Center, Duarte, CaliforniaDivision of Dermatology, City of Hope National Medical Center, Duarte, California; Correspondence to: Badri Modi, MD, Division of Dermatology, City of Hope National Cancer Center, 1500 East Duarte Rd, Duarte, CA 91010.http://www.sciencedirect.com/science/article/pii/S2352512620300242bullous pemphigoidcemiplimabprogrammed death ligand 1programmed cell death protein 1rituximabsquamous cell carcinoma
spellingShingle Cesar A. Virgen, MD, PhD
Tuyet A. Nguyen, MD
Cosimo Di Raimondo, MD
Arya Amini, MD
Kim A. Margolin, MD
Vishwas Parekh, MD
Farah R. Abdulla, MD
Badri Modi, MD
Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
JAAD Case Reports
bullous pemphigoid
cemiplimab
programmed death ligand 1
programmed cell death protein 1
rituximab
squamous cell carcinoma
title Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
title_full Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
title_fullStr Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
title_full_unstemmed Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
title_short Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
title_sort bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
topic bullous pemphigoid
cemiplimab
programmed death ligand 1
programmed cell death protein 1
rituximab
squamous cell carcinoma
url http://www.sciencedirect.com/science/article/pii/S2352512620300242
work_keys_str_mv AT cesaravirgenmdphd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT tuyetanguyenmd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT cosimodiraimondomd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT aryaaminimd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT kimamargolinmd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT vishwasparekhmd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT farahrabdullamd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma
AT badrimodimd bullouspemphigoidassociatedwithcemiplimabtherapyinapatientwithlocallyadvancedcutaneoussquamouscellcarcinoma